| (1) |
Wiersinga W.M. and Prummel M.F. (2000) An evidence-based
approach to the treatment of Graves' ophthalmopathy. Endocrinol. Metab.
Clin. North Am., 29: 297-319. |
| (2) |
Terwee C.B. et al. (1999) Test-retest reliability
of the GO-QOL: a disease-specific quality of life questionnaire for patients
with Graves' ophthalmopathy. J. Clin. Epidemiol., 52: 875-884. |
| (3) |
Terwee C.B. et al. (2001) Interpretation and
validation of changes in scores on the Graves' ophthalmopathy quality of
life questionnaire (GO-QOL) after different treatments. Clin. Endocrinol.
(Oxf.), 54: 391-398. |
| (4) |
Gerding M.N. et al. (1997) Quality of life in
patients with Graves' ophthalmopathy is markedly decreased: measurement
by the Medical Outcomes Study instrument. Thyroid, 7: 885-889. |
| (5) |
Valyasevi R.W. et al. (1999) Differentiation
of human orbital preadipocyte fibroblasts induces expression of functional
thyrotropin receptor. J. Clin. Endocrinol. Metab., 84: 2557-2562. |
| (6) |
Khoo D.H. et al. (1999) The combination of absent thyroid peroxidase
antibodies and high thyroid-stimulating immunoglobulin levels in Graves'
disease identifies a group at markedly increased risk of ophthalmopathy.
Thyroid, 9: 1175-1180. |
| (7) |
Gerding M.N. et al. (2000) Association of thyrotropin
receptor antibodies with the clinical features of Graves' ophthalmopathy.
Clin. Endocrinol. (Oxf.), 52: 267-271. |
| (8) |
Many M.C. et al. (1999) Development of an animal model of autoimmune
thyroid eye disease. J. Immunol., 162: 4966-4974. |
| (9) |
Ludgate M. (2000) Animal models of Graves' disease.
Eur. J. Endocrinol., 142: 1-8. |
| (10) |
Wiersinga W.M. and Prummel M.F. (2001) Pathogenesis of Graves'
ophthalmopathy-current understanding. J. Clin. Endocrinol. Metab., 86: 501-503. |
| (11) |
Wiersinga, W.M. and Bartalena, L. Epidemiology
and prevention of Graves' ophthalmopathy. Thyroid (in press). |
| (12) |
Nugent R.A. et al. (1990) Graves' orbitopathy:
correlation of CT and clinical findings. Radiology, 177: 675-682. |
| (13) |
Neigel J.M. et al. (1988) The crowded orbital
apex syndrome. Ophthalmology, 95: 1515-1521. |
| (14) |
Bartalena L. et al. (2000) Management of Graves'
ophthalmopathy: reality and perspectives. Endocr. Rev., 21: 168-199. |
| (15) |
Prummel M.F. et al. (1993) Randomized double-blind
trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet,
342: 949-954. |
| (16) |
Kahaly G.J. et al. (2000) Low- versus high-dose radiotherapy for
Graves' ophthalmopathy: a randomized, single blind trial. J. Clin. Endocrinol.
Metab., 85: 102-108. |
| (17) |
Nakahara H. et al. (1995) Graves' ophthalmopathy:
MR evaluation of 10-Gy vs 24-Gy irradiation combined with systemic corticosteroids.
Radiology, 196: 857-862. |
| (18) |
Mourits M.P. et al. (2000) Radiotherapy for Graves' orbitopathy:
randomized placebo-controlled study. Lancet, 355: 1505-1509. |
| (19) |
Gorman C.A. et al. (2001) A prospective, randomized,
double-blind, placebo-controlled study of orbital radiotherapy for Graves'
ophthalmopathy. Ophthalmology, 108: 1523-1534. |
| (20) |
Wiersinga W.M. (2002) Radiotherapy for Graves' ophthalmopathy.
The Dutch experience. Ophthal. Plast. Reconstr. Surg., 18: 175-176. |
| (21) |
Bartalena L. et al. (1983) Orbital cobalt irradiation
combined with systemic corticoids for Graves' ophthalmopathy: comparison
with systemic corticosteroids alone. J. Clin. Endocrinol. Metab., 56: 1139-1144. |
| (22) |
Marcocci C. et al. (1991) Orbital radiotherapy combined with high-dose
systemic glucocorticoids for Graves' ophthalmopathy is more effective than
orbital radiotherapy alone: results of a prospective study. J. Endocrinol.
Invest., 14: 853-860. |
| (23) |
Marcocci C. et al. (2001) Comparison of the effectiveness
and tolerability of intravenous or oral glucocorticoids associated with
orbital radiotherapy in the management of severe Graves' ophthalmopathy:
results of a prospective, single-blind randomized study. J. Clin. Endocrinol.
Metab., 86: 3562-3567. |
| (24) |
Prummel M.F. et al. (1989) Prednisone and cyclosporine in the treatment
of severe Graves' ophthalmopathy. N. Engl. J. Med., 321: 1353-1359. |
| (25) |
Kahaly G. et al. (1986) Cyclosporin and prednisone
vs prednisone in treatment of Graves' ophthalmopathy: a controlled, randomized
and prospective study. Eur. J. Clin. Invest., 16: 415-422. |
| (26) |
Kazatchkine M.D. and Kaveri S.V. (2001) Immunomodulation of autoimmune
and inflammatory diseases with intravenous immunoglobulins. N. Engl. J.
Med., 345: 747-755. |
| (27) |
Kahaly G. et al. (1996) Randomized trial of intravenous
immunoglobulins versus prednisolone in Graves' ophthalmopathy. Clin. Exp.
Immunol., 106: 197-202. |
| (28) |
Antonelli A. et al. (1992) High-dose intravenous immunoglobulin
treatment in Graves' ophthalmopathy. Acta Endocrinol., 126: 13-23. |
| (29) |
Pasquali D. et al. (2000) Somatostatin receptor
gene expression and inhibitory effects of octreotide on primary cultures
of orbital fibroblasts from Graves' ophthalmopathy. J. Mol. Endocrinol.,
25: 63-71. |
| (30) |
Kung A.W.C. et al. (1996) The effect of somatostatin versus corticosteroid
in the treatment of Graves' ophthalmopathy. Thyroid, 6: 381-384. |
| (31) |
Krassas G.E. et al. (1997) Lanreotide in the
treatment of patients with thyroid eye disease. Eur. J. Endocrinol., 136:
416-422. |
| (32) |
Balazs C.S. et al. (1997) Beneficial effect of pentoxifylline on
thyroid associated ophthalmopathy (TAO): a pilot study. J. Clin. Endocrinol.
Metab., 82: 1999-2002. |
| (33) |
Bouzas E.A. et al. (2000) Antioxidant agents
in the treatment of Graves' ophthalmopathy. Am. J. Ophthalmol., 129: 618-622. |
| (34) |
Koshiyama H. et al. (1994) Treatment of Graves' ophthalmopathy
with intravenous high-dose steroid following orbital irradiation. Thyroid,
4: 409-413. |
| (35) |
Matejka G. et al. (1998) Intravenous methylprednisolone
pulse therapy in the treatment of Graves' ophthalmopathy. Horm. Metab. Res.,
30: 93-98. |
| (36) |
Weissel M. and Hauff W. (2000) Fatal liver failure after high-dose
glucocorticoid pulse therapy in a patient with severe thyroid eye disease.
Thyroid, 10: 521. |
| (37) |
Snijders-Keilholz A. et al. (1996) Probable risk
of tumour induction after retro-orbital irradiation for Graves' ophthalmopathy.
Radiother. Oncol., 38: 69-71. |
| (38) |
Blank L.E.C.M. et al. (1996) Probable risk of tumor induction after
retro-orbital irradiation for Graves' ophthalmopathy. Radiother. Oncol.,
40: 187-188. |
| (39) |
Kahaly G.J. et al. (2000) Radiotherapy for Graves'
ophthalmopathy. In: Prummel M.F. (Ed) Recent Developments in Graves' Ophthalmopathy.
: Kluwer Academic Publishers. |
| (40) |
Kinyoun J.L. et al. (1984) Radiation retinopathy after orbital
irradiation for Graves' ophthalmopathy. Arch. Ophthalmol., 102: 1473-1476. |
| (41) |
Miller M.L. et al. (1991) Radiation retinopathy
after standard radiotherapy for thyroid related ophthalmopathy. Am. J. Ophthalmol.,
112: 600-601. |
| (42) |
Polak B.C.P. and Wijngaarde R. (1995) Radiation retinopathy in
patients with both diabetes mellitus and ophthalmic Graves' disease. Orbit,
14: 71-74. |
| (43) |
Feutzen G. et al. (1992) Risk factors for cyclosporine-induced
nephropathy in patients with autoimmune diseases. N. Engl. J. Med., 326:
1654-1660. |
| (44) |
Prummel M.F. (2001) Immunosuppressive therapy. In: Bahn R.S. (Ed)
Thyroid Eye Disease. : Kluwer Academic Publishers. |
| (45) |
Bradley E.A. and Garrity J.A. (1999) Surgical
management of Graves' ophthalmopathy. Endocrinologist, 9: 371-378. |
| (46) |
Kalmann R. et al. (1997) Coronal approach for rehabilitative orbital
decompression in Graves' ophthalmopathy. Br. J. Ophthalmol., 81: 41-45. |
| (47) |
Adenis J.P. et al. (1998) Treatment of proptosis
with fat removal orbital decompression in Graves' ophthalmopathy. Eur. J.
Ophthalmol., 8: 246-252. |
| (48) |
Coats D.K. et al. (1999) Early strabismus surgery for thyroid ophthalmopathy.
Ophthalmology, 106: 324-329. |
| (49) |
Gavin M.P. et al. (1997) Botulinum toxin-A in
the management of dysthyroid strabismus. Orbit, 16: 127-129. |
| (50) |
Mourits M.P.h. and Sasim I.V. (1999) A single technique to correct
various degrees of upper lid retraction in patients with Graves' orbitopathy.
Br. J. Ophthalmol., 83: 81-84. |
| (51) |
Olver J.M. (1998) Botulinum toxin A treatment
of overactive corrugator supercilii in thyroid eye disease. Br. J. Ophthalmol.,
82: 528-533. |
| (52) |
Prummel M.F. et al. (2000) A randomized placebo-controlled study
on radiotherapy for mild Graves' ophthalmopathy: effects on clinical severity
and quality of life. Endocr. J., 47: Suppl.:183. |
| (53) |
Perros P. et al. (1995) Natural history of thyroid
associated ophthalmopathy. Clin. Endocrinol. (Oxf.), 42: 45-50. |
| (54) |
Weetman A.P. and Wiersinga W.M. (1998) Current management of thyroid-associated
ophthalmopathy in Europe. Results of an international survey. Clin. Endocrinol.
(Oxf.), 49: 21-28. |
| (55) |
Bahn R. (1998) Cytokines in thyroid eye disease:
potential for anticytokine therapy. Thyroid, 8: 415-418. |